Document Detail


The renin-aldosterone system in dihydralazine therapy during hypertensive pregnancy.
MedLine Citation:
PMID:  365799     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Ten patients with hypertensive pregnancy were studied in hospital for 3 weeks. Plasma renin activity (PRA), the daily urinary excretion of aldosterone (dU-Aldo) and electrolytes were studied before and during dihydralazine therapy (25 mg 3 times daily). In one week the supine blood pressure decreased (p less than 0.05) without any discernible tachycardia. PRA increased in 3 days of the treatment by 50% (p less than 0.05) and this mean level was maintained. In dU-Aldo no change was found, however, during the study; and the excretions of sodium and potassium remained unchanged as well. In patients without diuretic therapy the basal PRA level before dihydralazine therapy was lower than in normal pregnancy. Also, in patients with preceding diuretic therapy the basal level of PRA was lower than during diuretics in gravidas without hypertension. Judging from the animal experiments, the rise in PRA might be seen as favorable for uteroplacental circulation in pregnancy hypertension.
Authors:
R Lammintausta
Related Documents :
8706309 - Determination of renin, angiotensin converting enzyme and angiotensin ii levels in huma...
12002199 - Paroxysmal hypertension, pheochromocytoma, and pregnancy.
12618519 - Excess placental soluble fms-like tyrosine kinase 1 (sflt1) may contribute to endotheli...
10584429 - Retinal detachment in postpartum preeclampsia and eclampsia: report of two cases.
16260209 - Hypertensive disease in pregnancies complicated by systemic lupus erythematosus.
10966899 - Multifrequency bioelectrical impedance analysis in women with a normal and hypertensive...
15343239 - L-arginine erythrocyte transport increases during pregnancy and immediately postpartum.
23103319 - Gestational weight gain within recommended ranges in consecutive pregnancies: a retrosp...
16353269 - Successful selective termination at 17 weeks' gestation in monochorionic monoamniotic t...
Publication Detail:
Type:  Clinical Trial; Journal Article    
Journal Detail:
Title:  International journal of clinical pharmacology and biopharmacy     Volume:  16     ISSN:  0340-0026     ISO Abbreviation:  Int J Clin Pharmacol Biopharm     Publication Date:  1978 Dec 
Date Detail:
Created Date:  1979-03-24     Completed Date:  1979-03-24     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  7505527     Medline TA:  Int J Clin Pharmacol Biopharm     Country:  GERMANY, WEST    
Other Details:
Languages:  eng     Pagination:  581-4     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aldosterone / urine*
Blood Pressure / drug effects
Clinical Trials as Topic
Dihydralazine / pharmacology*,  therapeutic use
Electrolytes / urine
Female
Heart Rate / drug effects
Humans
Hydralazine / analogs & derivatives*
Hypertension / drug therapy*,  metabolism
Pregnancy
Pregnancy Complications, Cardiovascular / drug therapy*,  metabolism
Renin / blood*
Time Factors
Chemical
Reg. No./Substance:
0/Electrolytes; 484-23-1/Dihydralazine; 52-39-1/Aldosterone; 86-54-4/Hydralazine; EC 3.4.23.15/Renin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Analysis of a certain type of 2 x 3 tables, exemplified by biopsy findings in a controlled clinical ...
Next Document:  Dose-response study of a new oral bronchodilator, NAB 365 (clenbuterol).